Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3703380rdf:typepubmed:Citationlld:pubmed
pubmed-article:3703380lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:3703380lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:3703380lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:3703380lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:3703380lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:3703380lifeskim:mentionsumls-concept:C0004927lld:lifeskim
pubmed-article:3703380lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:3703380lifeskim:mentionsumls-concept:C0002508lld:lifeskim
pubmed-article:3703380lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3703380lifeskim:mentionsumls-concept:C0205198lld:lifeskim
pubmed-article:3703380pubmed:issue1lld:pubmed
pubmed-article:3703380pubmed:dateCreated1986-6-9lld:pubmed
pubmed-article:3703380pubmed:abstractTextThe intracerebroventricular injection of the mast cell degranulator, compound 48/80 (C48/80, 10 micrograms/kg), produced a marked behavioural syndrome in rats which included head and body shakes, paw tremor, excessive grooming, unusual posture and gait, mild diarrhoea, piloerection, extreme agitation and irritability to touch, sedation and catatonia. Fifteen minutes after C48/80, the histamine concentrations were decreased significantly in all brain regions examined, i.e. the cortex, cerebellum, midbrain, medulla oblongata-pons (MO-P) and hypothalamus. The noradrenaline (NA) concentrations were decreased in the cerebellum, hypothalamus and MO-P, whereas the dopamine (DA) content was decreased in the MO-P only. The concentrations of serotonin were not affected. As such, the behaviours following the acute degranulation of brain mast cells by C48/80 may result predominantly from the release of histamine and possibly NA and DA.lld:pubmed
pubmed-article:3703380pubmed:languageenglld:pubmed
pubmed-article:3703380pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3703380pubmed:citationSubsetIMlld:pubmed
pubmed-article:3703380pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3703380pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3703380pubmed:statusMEDLINElld:pubmed
pubmed-article:3703380pubmed:monthMarlld:pubmed
pubmed-article:3703380pubmed:issn0304-3940lld:pubmed
pubmed-article:3703380pubmed:authorpubmed-author:JarrottBBlld:pubmed
pubmed-article:3703380pubmed:authorpubmed-author:FennessyM RMRlld:pubmed
pubmed-article:3703380pubmed:authorpubmed-author:QuinnM JMJlld:pubmed
pubmed-article:3703380pubmed:authorpubmed-author:LewisS JSJlld:pubmed
pubmed-article:3703380pubmed:issnTypePrintlld:pubmed
pubmed-article:3703380pubmed:day28lld:pubmed
pubmed-article:3703380pubmed:volume65lld:pubmed
pubmed-article:3703380pubmed:ownerNLMlld:pubmed
pubmed-article:3703380pubmed:authorsCompleteYlld:pubmed
pubmed-article:3703380pubmed:pagination84-8lld:pubmed
pubmed-article:3703380pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:meshHeadingpubmed-meshheading:3703380-...lld:pubmed
pubmed-article:3703380pubmed:year1986lld:pubmed
pubmed-article:3703380pubmed:articleTitleThe effects of intracerebroventricular administration of compound 48/80 on behaviour and regional brain amine concentrations in the rat.lld:pubmed
pubmed-article:3703380pubmed:publicationTypeJournal Articlelld:pubmed